Apr 27, 2023, 01:00 AM by User Not Found

Bio-IT World | Ginkgo Bioworks acquires an adeno-associated virus capsid discovery and engineering platform; Oxford Nanopore Technologies and bioMérieux SA have teamed up bring nanopore sequencing to the infectious disease diagnostics market, and the emergency of Large Language Models ops. Plus, new products from Metabolon, Cytiva, Vizgen, Agilent, and more.

Apr 26, 2023, 01:00 AM by User Not Found

Bio-IT World | Research autopsies are nothing new—the use of post-mortem tissues for cancer research has been ongoing since the end of the nineteenth century—but the Cancer Research UK-sponsored PEACE (posthumous evaluation of advanced cancer environment) study stands apart by virtue of its scope and scale. The pan-cancer initiative intends to enroll 500 patients across the country in hopes of understanding cancer evolution, drug resistance and why patients die of their disease.

Apr 25, 2023, 11:39 AM by

CSHL scientists have discovered that a protein called BRD8 goes out of control in glioblastoma, paralyzing P53. The discovery could help turn this deadly cancer into a treatable disease.

Apr 25, 2023, 11:39 AM by

Apr 25, 2023, 11:39 AM by

Apr 25, 2023, 11:39 AM by

Apr 25, 2023, 11:39 AM by

Form Bio, the provider of advanced computational life sciences technology today announced it has joined the PacBio Compatible program. As part of the program, the Form Bio platform has been verified as compatible with PacBio’s HiFi sequencing solutions, empowering corporate and academic research teams with a dramatically streamlined path from HiFi read data to breakthrough insights.

Apr 25, 2023, 11:39 AM by

Form Bio is a cutting-edge research and discovery platform for individuals and enterprises in life sciences. With an accessible, comprehensive and collaborative platform, Form Bio empowers scientists to efficiently and effectively harness the proliferation of data and computing power that has transformed the science of discovery. Form offers end-to-end integration of the discovery process with intuitive and easy-to-use software applications, combined with an open and adaptable collaborative environment. For more information on Form Bio, visit www.formbio.com

Apr 25, 2023, 11:39 AM by

New panel leverages Anchored Multiplex PCR (AMP™) chemistry and Archer Analysis to detect fusions, splice variants and more, enabling downstream application of precision medicine

Apr 25, 2023, 11:38 AM by

Innovative Application of Artificial Intelligence and Machine Learning Gives Healthcare Organizations Additional Capabilities to Stop Threat Actors by Enabling Them to Make Better Cyber Risk Decisions

Apr 25, 2023, 11:38 AM by

Elvin Wagenblast, PhD, of The Tisch Cancer Institute at Mount Sinai, received a CureSearch Young Investigator Award to develop a better understanding of AML in order to guide treatment for patients where standard chemotherapy is ineffective. The study is investigating how a normal blood stem cell can become cancerous. Dr. Wagenblast’s team is using state-of-the-art genome editing to understand vulnerabilities of the disease like never before.

Apr 25, 2023, 11:38 AM by

Domainex is honoured to announce it has received a King’s Award for Enterprise: International Trade 2023.

Apr 25, 2023, 11:38 AM by

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has expanded its oral dosage form capabilities at its newly built headquarters in Nottingham, UK.

Apr 25, 2023, 11:38 AM by

Tesis Biosciences Announces a Novel Pharmacogenomics Test Enabling Precise, Personalized Response to Wide Range of Pharmaceuticals

Apr 25, 2023, 11:38 AM by

OM1, a real-world data, outcomes, and technology company, launched PhenOM, a new AI solution, which gathers patient data points/phenotypes from structured and unstructured datasets – including clinical notes from messy EHRs – to create unique “fingerprints” for patients based on their medical history. With billions of data points from more than 300 patients, PhenOM is delivering personalized care from life science research to point-of-care clinical decision making.

Apr 25, 2023, 11:38 AM by

Verana Health Announces the Qdata Parkinson’s Disease Module at 2023 AAN Annual Meeting

Apr 25, 2023, 11:38 AM by

Linus Health, a digital health company focused on early detection of Alzheimer’s and other dementias, today announced the results of two new studies that further demonstrate the ability of digital cognitive assessments to identify early signs of cognitive impairment and dementia. The findings, which researchers will present at the American Academy of Neurology’s (AAN) 75th Annual Meeting, show that digital, AI-enhanced assessments can play a major role in helping providers efficiently assess older patients’ cognitive function and intervene early in the face of issues - a rising need as new treatments targeting early-stage Alzheimer’s disease become available.

Apr 25, 2023, 11:38 AM by

Cloud-based digital pathology platform helps CRO deliver more informed preclinical studies

Apr 25, 2023, 11:38 AM by

Apr 25, 2023, 11:38 AM by